Participants were randomized to receive placebo or 3 mg, 5 mg, or 10 mg daily of donepezil in a 1:1:1:1 fashion for 12 weeks following a 2-week prerandomization period. This exploratory study had ...
Participants received 5 mg donepezil daily or matching placebo for 2 weeks, then donepezil at 10 mg daily or matching placebo for 8 weeks; treatment was discontinued at 10 weeks, with an ...
Amneal Pharmaceuticals (AMRX) announced that the FDA has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which ...
As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback